{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:25:37Z","timestamp":1793319937105,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Although the clinical efficacy and safety of combination of pharmacotherapy and psychotherapy in the treatment of depressive disorders in children and adolescents have been studied, the results remain controversial. This meta-analysis aimed to study the short-term efficacy and acceptability of combined therapy for children and adolescents with depressive disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a systematic search in multiple databases for randomised controlled trials (RCTs), up to 31 December 2020, that assessed the combination of pharmacotherapy and psychotherapy against other active treatment options (pharmacotherapy, psychotherapy and placebo combined psychotherapy) in children and adolescents ( \u2264 18 years old) with depressive disorder. This study was registered with PROSPERO (CRD42020196701).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 14 RCTs involving 1,325 patients were included. For the primary and secondary outcomes, there were no statistically significant differences between the compared interventions in terms of remission (odds ratios [OR] = 1.37; 95% confidence interval [CI]: 0.93 to 2.04), acceptability (OR = 0.99; 95% CI: 0.72 to 1.38), efficacy (standardised mean differences = -0.07; 95% CI: -0.32 to 0.19), and suicidality (OR = 1.17; 95% CI: 0.67 to 2.06). Limited evidence showed that the combination of fluoxetine (OR = 1.90, 95% CI: 1.10 to 3.29) or non-selective serotonin reuptake inhibitors (non-SSRI) (OR = 2.46, 95% CI: 1.06 to 5.72) with cognitive-behavioural therapy (CBT) was superior to other active treatment options. Most included trials were rated as \u2018some concerns\u2019 in terms of risk of bias assessment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>There is no evidence from the limited available data that all combined therapies are superior to other active treatment options for the acute treatment of depressive disorder in children and adolescents. However, it showed that fluoxetine or non-SSRI pharmacotherapies combined with CBT might be superior to other therapies in short-term. Mixed characteristics (e.g. age) and small sample size of non-SSRI combined therapy may influence the generalisability of the results.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-022-03760-2","type":"journal-article","created":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T08:20:45Z","timestamp":1645518045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparative short-term efficacy and acceptability of a combination of pharmacotherapy and psychotherapy for depressive disorder in children and adolescents: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Yajie","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim","family":"Cuijpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueer","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanliang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,22]]},"reference":[{"key":"3760_CR1","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jpeds.2018.09.021","volume":"206","author":"RM Ghandour","year":"2019","unstructured":"Ghandour RM, Sherman LJ, Vladutiu CJ, Ali MM, Lynch SE, Bitsko RH, et al. Prevalence and Treatment of Depression, Anxiety, and Conduct Problems in US Children. J Pediatr. 2019;206:256\u201367 e3.","journal-title":"J Pediatr."},{"issue":"9820","key":"3760_CR2","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S0140-6736(11)60871-4","volume":"379","author":"A Thapar","year":"2012","unstructured":"Thapar A, Collishaw S, Pine DS, Thapar AK. Depression in adolescence. The Lancet. 2012;379(9820):1056\u201367.","journal-title":"The Lancet."},{"issue":"10036","key":"3760_CR3","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/S0140-6736(16)00648-6","volume":"387","author":"AH Mokdad","year":"2016","unstructured":"Mokdad AH, Forouzanfar MH, Daoud F, Mokdad AA, El Bcheraoui C, Moradi-Lakeh M, et al. Global burden of diseases, injuries, and risk factors for young people's health during 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet. 2016;387(10036):2383\u2013401.","journal-title":"The Lancet."},{"issue":"9783","key":"3760_CR4","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/S0140-6736(11)60512-6","volume":"377","author":"FM Gore","year":"2011","unstructured":"Gore FM, Bloem PJ, Patton GC, Ferguson J, Joseph V, Coffey C, et al. Global burden of disease in young people aged 10-24 years: a systematic analysis. Lancet. 2011;377(9783):2093\u2013102.","journal-title":"Lancet."},{"issue":"2","key":"3760_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/wps.20217","volume":"14","author":"X Zhou","year":"2015","unstructured":"Zhou X, Hetrick SE, Cuijpers P, Qin B, Barth J, Whittington CJ, et al. Comparative efficacy and acceptability of psychotherapies for depression in children and adolescents: A systematic review and network meta-analysis. World Psychiatry. 2015;14(2):207\u201322.","journal-title":"World Psychiatry."},{"issue":"10047","key":"3760_CR6","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(16)30385-3","volume":"388","author":"A Cipriani","year":"2016","unstructured":"Cipriani A, Zhou X, Del Giovane C, Hetrick SE, Qin B, Whittington C, et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet. 2016;388(10047):881\u201390.","journal-title":"Lancet."},{"issue":"6","key":"3760_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1600-0447.2009.01513.x","volume":"121","author":"P Cuijpers","year":"2010","unstructured":"Cuijpers P, van Straten A, Hollon SD, Andersson G. The contribution of active medication to combined treatments of psychotherapy and pharmacotherapy for adult depression: a meta-analysis. Acta Psychiatr Scand. 2010;121(6):415\u201323.","journal-title":"Acta Psychiatr Scand."},{"issue":"9","key":"3760_CR8","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S2215-0366(19)30215-9","volume":"6","author":"CG Davey","year":"2019","unstructured":"Davey CG, Chanen AM, Hetrick SE, Cotton SM, Ratheesh A, Amminger GP, et al. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial. Lancet Psychiatry. 2019;6(9):735\u201344.","journal-title":"Lancet Psychiatry."},{"issue":"7","key":"3760_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S2215-0366(20)30137-1","volume":"7","author":"X Zhou","year":"2020","unstructured":"Zhou X, Teng T, Zhang Y, Del Giovane C, Furukawa TA, Weisz JR, et al. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2020;7(7):581\u2013601.","journal-title":"Lancet Psychiatry."},{"issue":"4","key":"3760_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1176\/appi.ajp.2009.09020265","volume":"166","author":"MM Weissman","year":"2009","unstructured":"Weissman MM. Teenaged, depressed, and treatment resistant: what predicts self-harm? Am J Psychiatry. 2009;166(4):385\u20137.","journal-title":"Am J Psychiatry."},{"key":"3760_CR11","doi-asserted-by":"crossref","unstructured":"Del Giovane CCS, Cipriani A. Combining Pharmacological and Nonpharmacological Interventions in Network Meta-analysis in Psychiatry. JAMA Psychiatry. 2019;0574.","DOI":"10.1001\/jamapsychiatry.2019.0574"},{"issue":"2","key":"3760_CR12","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1371\/journal.pmed.0040061","volume":"4","author":"IGL Boutron","year":"2007","unstructured":"Boutron IGL, Estellat C, Moher D, Hr\u00f3bjartsson A, Ravaud P. Reporting methods of blinding in randomized trials assessing nonpharmacological treatments. PLoS Med. 2007;4(2):e61.","journal-title":"PLoS Med."},{"key":"3760_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.","journal-title":"BMJ."},{"issue":"6","key":"3760_CR14","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.cpr.2010.06.001","volume":"30","author":"PLJ Cuijpers","year":"2010","unstructured":"Cuijpers PLJ, Hofmann SG, Andersson G. Self-reported versus clinician-rated symptoms of depression as outcome measures in psychotherapy research on depression: a meta-analysis. Clin Psychol Rev. 2010;30(6):768\u201378.","journal-title":"Clin Psychol Rev"},{"key":"3760_CR15","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Bmj. 2009;339:b2535.","DOI":"10.1136\/bmj.b2535"},{"issue":"3","key":"3760_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/00004583-200003000-00008","volume":"39","author":"GA Bernstein","year":"2000","unstructured":"Bernstein GA, Borchardt CM, Perwien AR, Crosby RD, Kushner MG, Thuras PD, et al. Imipramine plus cognitive-behavioral therapy in the treatment of school refusal. J Am Acad Child Adolesc Psychiatry. 2000;39(3):276\u201383.","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"issue":"9","key":"3760_CR17","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/S0890-8567(09)62194-8","volume":"44","author":"G Clarke","year":"2005","unstructured":"Clarke G, Debar L, Lynch F, Powell J, Gale J, O'Connor E, et al. A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication. J Am Acad Child Adolesc Psychiatry. 2005;44(9):888\u201398.","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"issue":"10","key":"3760_CR18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.addbeh.2009.03.008","volume":"34","author":"JR Cornelius","year":"2009","unstructured":"Cornelius JR, Bukstein OG, Wood DS, Kirisci L, Douaihy A, Clark DB. Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder. Addict Behav. 2009;34(10):905\u20139.","journal-title":"Addict Behav."},{"issue":"6","key":"3760_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/1099-1077(200008)15:6<461::AID-HUP209>3.0.CO;2-J","volume":"15","author":"D Deas","year":"2000","unstructured":"Deas D, Randall CL, Roberts JS, Anton RF. A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot study. Hum Psychopharmacol. 2000;15(6):461\u20139.","journal-title":"Hum Psychopharmacol."},{"issue":"sup1","key":"3760_CR20","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1080\/15374416.2016.1233500","volume":"48","author":"MA Fristad","year":"2019","unstructured":"Fristad MA, Vesco AT, Young AS, Healy KZ, Nader ES, Gardner W, et al. Pilot Randomized Controlled Trial of Omega-3 and Individual-Family Psychoeducational Psychotherapy for Children and Adolescents With Depression. J Clin Child Adolesc Psychol. 2019;48(sup1):S105\u2013S18.","journal-title":"J Clin Child Adolesc Psychol."},{"issue":"14","key":"3760_CR21","doi-asserted-by":"publisher","first-page":"iii-iv, ix-60","DOI":"10.3310\/hta12140","volume":"12","author":"IM Goodyer","year":"2008","unstructured":"Goodyer IM, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, et al. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial. Health Technol Assess. 2008;12(14):iii-iv, ix-60.","journal-title":"Health Technol Assess."},{"issue":"1","key":"3760_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jaac.2018.06.032","volume":"58","author":"M Gunlicks-Stoessel","year":"2019","unstructured":"Gunlicks-Stoessel M, Mufson L, Bernstein G, Westervelt A, Reigstad K, Klimes-Dougan B, et al. Critical Decision Points for Augmenting Interpersonal Psychotherapy for Depressed Adolescents: A Pilot Sequential Multiple Assignment Randomized Trial. J Am Acad Child Adolesc Psychiatry. 2019;58(1):80\u201391.","journal-title":"J Am Acad Child Adolesc Psychiatry."},{"issue":"3","key":"3760_CR23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.psychres.2014.11.021","volume":"225","author":"F Iftene","year":"2015","unstructured":"Iftene F, Predescu E, Stefan S, David D. Rational-emotive and cognitive-behavior therapy (REBT\/CBT) versus pharmacotherapy versus REBT\/CBT plus pharmacotherapy in the treatment of major depressive disorder in youth; a randomized clinical trial. Psychiatry Res. 2015;225(3):687\u201394.","journal-title":"Psychiatry Res."},{"issue":"5","key":"3760_CR24","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.chb.2012.05.015","volume":"28","author":"SM Kim","year":"2012","unstructured":"Kim SM, Han DH, Lee YS, Renshaw PF. Combined cognitive behavioral therapy and bupropion for the treatment of problematic on-line game play in adolescents with major depressive disorder. Computers in Human Behavior. 2012;28(5):1954\u20139.","journal-title":"Computers in Human Behavior."},{"issue":"1","key":"3760_CR25","first-page":"149","volume":"33","author":"MW Mandoki","year":"1997","unstructured":"Mandoki MW, Tapia MR, Tapia MA, Sumner GS, Parker JL. Venlafaxine in the treatment of children and adolescents with major depression. Psychopharmacol Bull. 1997;33(1):149\u201354.","journal-title":"Psychopharmacol Bull."},{"issue":"7","key":"3760_CR26","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1001\/jama.292.7.807","volume":"292","author":"J March","year":"2004","unstructured":"March J, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292(7):807\u201320.","journal-title":"JAMA."},{"issue":"11","key":"3760_CR27","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1001\/archpedi.161.11.1026","volume":"161","author":"PD Riggs","year":"2007","unstructured":"Riggs PD, Mikulich-Gilbertson SK, Davies RD, Lohman M, Klein C, Stover SK. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch Pediatr Adolesc Med. 2007;161(11):1026\u201334.","journal-title":"Arch Pediatr Adolesc Med."},{"issue":"10","key":"3760_CR28","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1097\/01.chi.0000233157.21925.71","volume":"45","author":"GA Melvin","year":"2006","unstructured":"Melvin GA, Tonge BJ, King NJ, Heyne D, Gordon MS, Klimkeit E. A Comparison of Cognitive-Behavioral Therapy, Sertraline, and Their Combination for Adolescent Depression. J Am Academy Child Adolescent Psychiatr. 2006;45(10):1151\u201361.","journal-title":"J Am Academy Child Adolescent Psychiatr"},{"issue":"6","key":"3760_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1192\/bjp.bp.109.075853","volume":"197","author":"B Dubicka","year":"2010","unstructured":"Dubicka B, Elvins R, Roberts C, Chick G, Wilkinson P, Goodyer IM. Combined treatment with cognitive-behavioural therapy in adolescent depression: meta-analysis. Br J Psychiatry. 2010;197(6):433\u201340.","journal-title":"Br J Psychiatry."},{"key":"3760_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.2147\/PRBM.S13780","volume":"4","author":"SE Hetrick","year":"2011","unstructured":"Hetrick SE, Cox GR, Merry SN. Treatment-resistant depression in adolescents: is the addition of cognitive behavioral therapy of benefit? Psychol Res Behav Manag. 2011;4:97\u2013112.","journal-title":"Psychol Res Behav Manag."},{"key":"3760_CR31","doi-asserted-by":"crossref","unstructured":"Cox GR, Callahan P, Churchill R, Hunot V, Merry SN, Parker AG, et al. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents. Cochrane Database Syst Rev. 2014;(11):CD008324.","DOI":"10.1002\/14651858.CD008324.pub3"},{"key":"3760_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1471-244X-12-61","volume":"12","author":"A von Wolff","year":"2012","unstructured":"von Wolff A, H\u00f6lzel LP, Westphal A, H\u00e4rter M, Kriston L. Combination of pharmacotherapy and psychotherapy in the treatment of chronic depression: a systematic review and meta-analysis. BMC Psychiatry. 2012;12:61.","journal-title":"BMC Psychiatry."},{"issue":"5","key":"3760_CR33","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.clinthera.2017.03.017","volume":"39","author":"AI Rohden","year":"2017","unstructured":"Rohden AI, Benchaya MC, Camargo RS, Moreira TC, Barros HMT, Ferigolo M. Dropout Prevalence and Associated Factors in Randomized Clinical Trials of Adolescents Treated for Depression: Systematic Review and Meta-analysis. Clin Ther. 2017;39(5):971\u201392 e4.","journal-title":"Clin Ther."},{"issue":"4","key":"3760_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1310\/hct0704-203","volume":"7","author":"R DiFrancesco","year":"2006","unstructured":"DiFrancesco R, Rosenkranz SL, Craft J, Morse GD. Tutorial reduces protocol deviations in multicenter ACTG trials with pharmacology endpoints. HIV Clin Trials. 2006;7(4):203\u20139.","journal-title":"HIV Clin Trials."},{"key":"3760_CR35","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.mppsy.2007.04.005","volume":"6","author":"JND Nash","year":"2007","unstructured":"Nash JND. Antidepressants. Psychiatry. 2007;6:289\u201394.","journal-title":"Psychiatry."},{"issue":"9864","key":"3760_CR36","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0140-6736(12)61552-9","volume":"381","author":"N Wiles","year":"2013","unstructured":"Wiles N, Thomas L, Abel A, Ridgway N, Turner N, Campbell J, et al. Cognitive behavioural therapy as an adjunct to pharmacotherapy for primary care based patients with treatment resistant depression: results of the CoBalT randomised controlled trial. Lancet. 2013;381(9864):375\u201384.","journal-title":"Lancet."},{"key":"3760_CR37","first-page":"19","volume":"1","author":"T Danielle","year":"2008","unstructured":"Danielle T, Maud E, Jean-Yves FJPCH. Adherence to treatment in adolescents. 2008;1:19\u201324.","journal-title":"Adherence to treatment in adolescents."},{"key":"3760_CR38","unstructured":"Administration UFaD. Suicidality in children and adolescents being treated with antidepressant medications. US Food and Drug Administration. Oct. 2004;15."},{"key":"3760_CR39","doi-asserted-by":"crossref","unstructured":"McCulloch A, Kroll L, Glass J, Dubicka B. A systematic review of the characteristics of adolescents with major depressive disorder in randomised controlled treatment trials. The. Eur J Psychiatry. 2021.","DOI":"10.1016\/j.ejpsy.2021.07.001"},{"issue":"1","key":"3760_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ebmental-2019-300080","volume":"22","author":"A Cipriani","year":"2019","unstructured":"Cipriani A, Tomlinson A. Providing the most appropriate care to our individual patients. Evid Based Ment Health. 2019;22(1):1\u20132.","journal-title":"Evid Based Ment Health."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-03760-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-022-03760-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-03760-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T08:23:59Z","timestamp":1645518239000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-022-03760-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,22]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3760"],"URL":"https:\/\/doi.org\/10.1186\/s12888-022-03760-2","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,22]]},"assertion":[{"value":"26 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}